Aldosterone/renin ratio determines peripheral and central blood pressure values over a broad range.

[1]  E. Benjamin,et al.  Multimarker Approach to Evaluate Correlates of Vascular Stiffness: The Framingham Heart Study , 2009, Circulation.

[2]  W. Young,et al.  Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. , 2008, The Journal of clinical endocrinology and metabolism.

[3]  J. Ménard,et al.  High plasma aldosterone and low renin predict blood pressure increase and hypertension in middle-aged Caucasian populations , 2008, Journal of Human Hypertension.

[4]  N. Kaplan.  Déjà vu for primary aldosteronism , 2008, The Lancet.

[5]  A. Triantafyllou,et al.  Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study , 2008, The Lancet.

[6]  Robert D. Toto,et al.  Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. , 2008, Hypertension.

[7]  S. Schinner,et al.  New Mechanisms to Control Aldosterone Synthesis , 2008, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[8]  M. Boaz,et al.  The association between the renin–angiotensin–aldosterone system and arterial stiffness in young healthy subjects , 2008, Clinical endocrinology.

[9]  J. Connell,et al.  A lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function. , 2008, Endocrine reviews.

[10]  Hyung-Suk Kim,et al.  Salt-Sensitive Blood Pressure in Mice With Increased Expression of Aldosterone Synthase , 2008, Hypertension.

[11]  N. Kaplan.  Is there an unrecognized epidemic of primary aldosteronism? Con. , 2007, Hypertension.

[12]  D. Levy,et al.  Clinical and Genetic Correlates of Aldosterone-to-Renin Ratio and Relations to Blood Pressure in a Community Sample , 2007, Hypertension.

[13]  Nader Rifai,et al.  Multiple Biomarkers and the Risk of Incident Hypertension , 2007, Hypertension.

[14]  F. Beuschlein,et al.  Automated chemiluminescence-immunoassay for aldosterone during dynamic testing: comparison to radioimmunoassays with and without extraction steps. , 2006, Clinical chemistry.

[15]  D. Levy,et al.  Cross-Sectional Relations of Multiple Biomarkers From Distinct Biological Pathways to Brachial Artery Endothelial Function , 2006, Circulation.

[16]  N. Brown.  Aldosterone and end-organ damage , 2005, Clinical science.

[17]  S. Turner,et al.  Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity. , 2005, Clinical chemistry.

[18]  P. Torjesen,et al.  Low-renin status in therapy-resistant hypertension: a clue to efficient treatment , 2004, Journal of hypertension.

[19]  C. Maser-Gluth,et al.  Rapid screening test for primary hyperaldosteronism: ratio of plasma aldosterone to renin concentration determined by fully automated chemiluminescence immunoassays. , 2004, Clinical chemistry.

[20]  D. Levy,et al.  Serum aldosterone and the incidence of hypertension in nonhypertensive persons. , 2004, The New England journal of medicine.

[21]  T. Philipp,et al.  Comparison of active renin concentration and plasma renin activity for the diagnosis of primary hyperaldosteronism in patients with an adrenal mass. , 2004, European journal of endocrinology.

[22]  L. Hunyady,et al.  Control of aldosterone secretion: a model for convergence in cellular signaling pathways. , 2004, Physiological reviews.

[23]  W. Scherbaum,et al.  Human adipocytes secrete mineralocorticoid-releasing factors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[25]  M. Volpe,et al.  The renin-angiotensin system as a risk factor and therapeutic target for cardiovascular and renal disease. , 2002, Journal of the American Society of Nephrology : JASN.

[26]  J. Hensen,et al.  Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism. , 2002, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[27]  W. März,et al.  Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. , 2001, Pharmacogenomics.

[28]  P. Donnan,et al.  Aldosterone to renin ratio as a determinant of exercise blood pressure response in hypertensive patients , 2001, Journal of Human Hypertension.

[29]  X. Jeunemaître,et al.  Altered Adrenal Sensitivity to Angiotensin II in Low-Renin Essential Hypertension , 1999 .

[30]  H. Dörr,et al.  Value of direct measurement of active renin concentrations in congenital adrenal hyperplasia due to 21-hydroxylase deficiency , 1996, European Journal of Pediatrics.

[31]  T. MacDonald,et al.  The neurohormonal natural history of essential hypertension: towards primary or tertiary aldosteronism? , 2002, Journal of hypertension.